Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea

Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema

NCT00570544 ·Status: COMPLETED

Tiotropium (Spiriva) Rehabilitation Study

NCT00274521 ·Status: COMPLETED ·Phase: PHASE3

A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00144326 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example

NCT01036763 ·Status: COMPLETED

Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

NCT00274053 ·Status: COMPLETED ·Phase: PHASE3

Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation

NCT02172521 ·Status: COMPLETED

Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

NCT00274027 ·Status: COMPLETED ·Phase: PHASE3

Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172482 ·Status: COMPLETED

Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders

NCT00274014 ·Status: COMPLETED ·Phase: PHASE3

Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.

NCT02172547 ·Status: COMPLETED

Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

NCT00615992 ·Status: COMPLETED

Spiriva® Assessment of FEV1 (SAFE)

NCT00277264 ·Status: COMPLETED ·Phase: PHASE3

Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease

NCT02177318 ·Status: COMPLETED

Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease

NCT01072396 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

NCT00144339 ·Status: COMPLETED ·Phase: PHASE3

Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

NCT00239408 ·Status: COMPLETED ·Phase: PHASE4

Tiotropium In Exercise

NCT00525512 ·Status: COMPLETED ·Phase: PHASE4

Special Survey Long-term Treatment With Tiotropium on COPD

NCT00638183 ·Status: COMPLETED

A Prescription-Event Monitoring (PEM) Study of Tiotropium

NCT02196194 ·Status: COMPLETED

Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities

NCT00621582 ·Status: COMPLETED

Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients

NCT00620516 ·Status: COMPLETED

Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00239499 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT05986591 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT03118765 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence Study of Tiotropium Bromide Inhalation Powder

NCT05161156 ·Status: COMPLETED ·Phase: PHASE3